FDA issues Class I recall of C.R. Bard wound-healing graft

March 4, 2011 by MassDevice staff

The FDA issues a Class I recall for C.R. Bard's Davol XenMatrix surgical graft over fears the fabric-like device could contain toxins.

C.R. Bard

The FDA issued a Class I recall of a surgical graft manufactured by C.R. Bard Inc. (NYSE:BCR) subsidiary Davol Inc. on fears it might contain a toxin.

The federal watchdog agency is recalling several lots of Davol's XenMatrix product because of concerns that it might contain elevated levels of endotoxins. The toxins, which are found in certain bacteria, can cause fatal illness at higher levels, according to the FDA.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp